Ignace B. Vergote, MD, PhD
Professor
University Hospital Leuven
Dept. of OB/GYN
Gasthuisberg
Leuven
Belgium
3000
Papers:
4 - Seminal Abstract
A phase III, randomized, double-blind trialof weekly paclitaxel plus the angiopoientin 1 and 2 inhibitor, trebananib, or placebo in women with recurrent ovarian cancer: TRINOVA-1
132 - Focused Plenary
Analysis of intermediate clinical endpoints from a Phase II trial of olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC)
446 - Poster Session B
Trial in Progress: A randomized double-blind phase 3 trial comparing vintafolide + pegylated liposomal doxorubicin (PLD) versus PLD + placebo in patients with platinum-resistant ovarian cancer (PROCEED)